Quote:

---

Who will best help get this drug into the hands of the patients that need it?

---

The current team running the Brazil trial -- easily the #1 plan for getting the fastest approval and revenue.

Or you can throw your lot in with a group that seems amateurish, at best, and their plan is to exploit the cult popularity of a mediocre scientist with a shitty lab company and a strategy to pursue cancer and long haulers which will delay revenue by 12-18 months, at the earliest.